Company · CIK 0001689813 · SIC 2834 — Pharmaceutical Preparations
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2019 SForm 4 → | Mar 1, 5:59 pm EST | Declan DooganDirector | 101,024 | $46.26 | $4,672,922 | 1,026,002 | −8.96% | plan? |
| Feb 22, 2019 SForm 4 → | Feb 26, 5:44 pm EST | Declan DooganDirector | 76,898 | $44.90 | $3,452,588 | 1,099,981 | −6.53% | plan? |
| Feb 21, 2019 SForm 4 → | Feb 25, 4:40 pm EST | Julia P GregoryDirector | 12,000 | $43.56 | $522,720 | 0 | −100% | plan? |
| Feb 21, 2019 MForm 4 → | Feb 25, 4:40 pm EST | Julia P GregoryDirector | 12,000 | $23.63 | $283,560 | 12,000 | — | plan? |
| Feb 15, 2019 SForm 4 → | Feb 20, 5:40 pm EST | Declan DooganDirector | 2,078 | $45.48 | $94,509 | 1,113,924 | −0.19% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 4:42 pm EST | Declan DooganDirector | 40,000 | $44.31 | $1,772,307 | 1,116,002 | −3.46% | plan? |
| Feb 4, 2019 MForm 4 → | Feb 6, 6:21 pm EST | Eric AguiarDirector | 35,218 | $33.01 | $1,162,378 | 0 | — | plan? |
| Jan 10, 2019 SForm 4 → | Jan 14, 5:50 pm EST | John TiltonChief Commercial Officer | 10,500 | $37.67 | $395,535 | 0 | −100% | plan? |
| Jan 10, 2019 MForm 4 → | Jan 14, 5:50 pm EST | John TiltonChief Commercial Officer | 10,500 | $9.29 | $97,545 | 10,500 | — | plan? |
| Dec 3, 2018 SForm 4 → | Dec 6, 4:26 pm EST | Declan DooganDirector | 40,000 | $41.95 | $1,678,000 | 1,156,002 | −3.34% | plan? |
| Jul 23, 2018 GForm 5 → | Feb 14, 2019, 4:32 pm EST | Vlad CoricChief Executive Officer, Director | 35,000 | — | — | 490,000 | — | plan? |
| Jun 26, 2018 GForm 5 → | Feb 14, 2019, 4:28 pm EST | Robert BermanChief Medical Officer | 6,000 | — | — | 228,551 | — | plan? |
| Jun 15, 2018 SForm 4 → | Jun 19, 4:43 pm EDT | Kimberly GentileVP of Operations | 12,500 | $40.02 | $500,250 | 0 | −100% | plan? |
| Jun 15, 2018 MForm 4 → | Jun 19, 4:43 pm EDT | Kimberly GentileVP of Operations | 12,500 | $0.61 | $7,625 | 12,500 | — | plan? |
| Jun 11, 2018 SForm 4/A → | Jun 20, 9:29 pm EDT | Robert BermanChief Medical Officer | 76,692 | $36.36 | $2,788,707 | 244,000 | −23.9% | plan? |
| Jun 8, 2018 SForm 4 → | Jun 12, 4:12 pm EDT | Robert BermanChief Medical Officer | 104,155 | $36.33 | $3,784,303 | 234,551 | −30.8% | plan? amended |
| Jun 5, 2018 SForm 4 → | Jun 7, 4:29 pm EDT | Robert BermanChief Medical Officer | 25,845 | $36.01 | $930,714 | 327,427 | −7.32% | plan? |
| Jun 4, 2018 SForm 4 → | Jun 6, 4:19 pm EDT | Declan DooganDirector | 89,216 | $35.25 | $3,145,112 | 1,196,002 | −6.94% | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 5:29 pm EDT | Declan DooganDirector | 110,784 | $35.03 | $3,881,056 | 1,285,218 | −7.94% | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 5:26 pm EDT | Vlad CoricChief Executive Officer, Director | 50,000 | $35.02 | $1,750,900 | 525,000 | −8.70% | plan? |
| May 30, 2018 SForm 4 → | May 30, 6:02 pm EDT | James EngelhartChief Financial Officer | 5,000 | $35.00 | $175,000 | 0 | −100% | plan? |
| May 30, 2018 MForm 4 → | May 30, 6:02 pm EDT | James EngelhartChief Financial Officer | 5,000 | $0.61 | $3,050 | 5,000 | — | plan? |
| May 10, 2018 SForm 4 → | May 14, 5:11 pm EDT | Robert BermanChief Medical Officer | 35,000 | $26.82 | $938,706 | 348,000 | −9.14% | plan? |
| May 7, 2018 SForm 4 → | May 9, 4:53 pm EDT | James EngelhartChief Financial Officer | 2,500 | $27.67 | $69,175 | 0 | −100% | plan? |
| Apr 10, 2018 SForm 4 → | Apr 12, 5:02 pm EDT | Robert BermanChief Medical Officer | 35,000 | $24.66 | $863,132 | 376,000 | −8.52% | plan? |
| Mar 14, 2018 AForm 4 → | Mar 15, 6:20 pm EDT | Albert ChaDirector | 72,727 | $27.50 | $1,999,993 | 2,049,545 | — | plan? |
| Mar 12, 2018 SForm 4 → | Mar 14, 5:05 pm EDT | Robert BermanChief Medical Officer | 35,000 | $30.11 | $1,053,929 | 404,000 | −7.97% | plan? |
| Mar 1, 2018 SForm 4 → | Mar 5, 4:31 pm EST | Kimberly GentileVP of Operations | 5,000 | $32.87 | $164,344 | 0 | −100% | plan? |
| Mar 1, 2018 MForm 4 → | Mar 5, 4:31 pm EST | Kimberly GentileVP of Operations | 5,000 | $0.61 | $3,050 | 5,000 | — | plan? |
| Feb 21, 2018 SForm 4 → | Feb 23, 5:52 pm EST | James EngelhartChief Financial Officer | 538 | $29.60 | $15,925 | 3,038 | −15.0% | plan? |
| Feb 12, 2018 SForm 4 → | Feb 14, 4:31 pm EST | Robert BermanChief Medical Officer | 35,000 | $30.42 | $1,064,576 | 432,000 | −7.49% | plan? |
| Feb 1, 2018 SForm 4 → | Feb 2, 6:18 pm EST | Kimberly GentileVP of Operations | 5,000 | $32.78 | $163,900 | 0 | −100% | plan? |
| Feb 1, 2018 MForm 4 → | Feb 2, 6:18 pm EST | Kimberly GentileVP of Operations | 5,000 | $0.61 | $3,050 | 5,000 | — | plan? |
| Jan 31, 2018 SForm 4 → | Feb 2, 6:17 pm EST | Gregory BaileyDirector | 50,000 | $33.71 | $1,685,352 | 2,475,101 | −1.98% | plan? |
| Jan 23, 2018 SForm 4 → | Jan 25, 7:28 pm EST | Gregory BaileyDirector | 16,000 | $32.79 | $524,640 | 2,525,101 | −0.63% | plan? |
| Jan 22, 2018 SForm 4 → | Jan 24, 7:00 pm EST | James EngelhartChief Financial Officer | 10,000 | $32.50 | $325,000 | 3,576 | −73.7% | plan? |
| Jan 22, 2018 MForm 4 → | Jan 24, 7:00 pm EST | James EngelhartChief Financial Officer | 10,000 | $0.61 | $6,100 | 13,576 | — | plan? |
| Jan 19, 2018 SForm 4/A → | Jan 25, 4:13 pm EST | PORTAGE BIOTECH INC.Other | 59,396 | $31.31 | $1,859,406 | 54,494 | −52.2% | plan? |
| Jan 19, 2018 SForm 4 → | Jan 24, 7:01 pm EST | PORTAGE BIOTECH INC.Other | 59,396 | $135,520.34 | $8,049,365,832 | 54,494 | −52.2% | plan? late amended |
| Jan 19, 2018 SForm 4 → | Jan 23, 6:57 pm EST | Gregory BaileyDirector | 49,000 | $30.76 | $1,507,459 | 2,541,101 | −1.89% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 6:57 pm EST | Declan DooganDirector | 128,058 | $26.95 | $3,451,297 | 1,396,002 | −8.40% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 6:37 pm EST | Gregory BaileyDirector | 40,000 | $26.52 | $1,060,800 | 2,590,101 | −1.52% | plan? |
| Jan 10, 2018 SForm 4 → | Jan 12, 7:00 pm EST | Declan DooganDirector | 121,942 | $26.78 | $3,265,537 | 1,178,058 | −9.38% | plan? |
| Jan 10, 2018 SForm 4 → | Jan 12, 6:59 pm EST | Robert BermanChief Medical Officer | 35,000 | $27.52 | $963,133 | 466,000 | −6.99% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 9, 6:23 pm EST | PORTAGE BIOTECH INC.10% Owner | 84,881 | $30.06 | $2,551,573 | 6,216,619 | −1.35% | plan? |
| Jan 4, 2018 SForm 4/A → | Jan 11, 11:06 am EST | PORTAGE BIOTECH INC.10% Owner | 4,350 | $28.62 | $124,504 | 6,301,500 | −0.07% | plan? |
| Jan 4, 2018 SForm 4 → | Jan 5, 10:29 am EST | PORTAGE BIOTECH INC.10% Owner | 4,350 | $28.62 | $124,504 | 124,371 | −3.38% | plan? amended |
| Jan 3, 2018 SForm 4 → | Jan 5, 8:05 pm EST | Gregory BaileyDirector | 50,000 | $28.71 | $1,435,528 | 1,170,299 | −4.10% | plan? |
| Jan 3, 2018 SForm 4 → | Jan 4, 4:15 pm EST | PORTAGE BIOTECH INC.10% Owner | 35,650 | $28.61 | $1,020,071 | 6,305,850 | −0.56% | plan? |
| Jan 2, 2018 SForm 4 → | Jan 3, 5:28 pm EST | Kimberly GentileVP of Operations | 5,000 | $27.60 | $138,000 | 0 | −100% | plan? |
| Jan 2, 2018 MForm 4 → | Jan 3, 5:28 pm EST | Kimberly GentileVP of Operations | 5,000 | $0.61 | $3,050 | 5,000 | — | plan? |
| Dec 20, 2017 SForm 4 → | Dec 22, 5:58 pm EST | Gregory BaileyDirector | 39,430 | $26.31 | $1,037,290 | 1,220,299 | −3.13% | plan? |
| Dec 19, 2017 SForm 4 → | Dec 20, 5:57 pm EST | Robert BermanChief Medical Officer | 10,000 | $24.10 | $241,000 | 494,000 | −1.98% | plan? |
| Dec 11, 2017 SForm 4 → | Dec 14, 7:08 am EST | Robert BermanChief Medical Officer | 25,000 | $21.28 | $532,000 | 502,000 | −4.74% | plan? late |
| Dec 1, 2017 SForm 4 → | Dec 5, 4:02 pm EST | Kimberly GentileVP of Operations | 5,000 | $21.99 | $109,962 | 0 | −100% | plan? |
| Dec 1, 2017 MForm 4 → | Dec 5, 4:02 pm EST | Kimberly GentileVP of Operations | 5,000 | $0.61 | $3,050 | 5,000 | — | plan? |
| Nov 30, 2017 GForm 5 → | Feb 12, 2018, 4:50 pm EST | Vlad CoricChief Executive Officer, Director | 50,000 | — | — | 550,000 | — | plan? |
| Nov 29, 2017 GForm 5 → | Feb 13, 2018, 5:56 pm EST | Robert BermanChief Medical Officer | 6,000 | — | — | 488,000 | — | plan? |
| Nov 29, 2017 SForm 4 → | Dec 1, 7:27 pm EST | Gregory BaileyDirector | 9,970 | $25.48 | $254,005 | 1,259,729 | −0.79% | plan? |
| Nov 24, 2017 SForm 4 → | Nov 28, 7:19 pm EST | Gregory BaileyDirector | 20,600 | $25.92 | $534,012 | 1,269,699 | −1.60% | plan? |
| Nov 9, 2017 SForm 4 → | Nov 14, 5:52 pm EST | James EngelhartChief Financial Officer | 30,538 | $26.58 | $811,561 | 3,576 | −89.5% | plan? late amended |
| Nov 9, 2017 MForm 4 → | Nov 14, 5:52 pm EST | James EngelhartChief Financial Officer | 30,538 | $0.61 | $18,628 | 12,514 | — | plan? late amended |
| Nov 9, 2017 SForm 4 → | Nov 14, 5:51 pm EST | Robert BermanChief Medical Officer | 160,000 | $25.76 | $4,122,064 | 522,000 | −23.5% | plan? late |
| Nov 1, 2017 SForm 4 → | Nov 2, 5:57 pm EDT | Kimberly GentileVP of Operations | 5,000 | $29.28 | $146,385 | 0 | −100% | plan? |
| Nov 1, 2017 MForm 4 → | Nov 2, 5:57 pm EDT | Kimberly GentileVP of Operations | 5,000 | $0.61 | $3,050 | 5,000 | — | plan? |
| Nov 1, 2017 SForm 4 → | Nov 2, 5:55 pm EDT | John TiltonChief Commercial Officer | 30,000 | $29.25 | $877,586 | 0 | −100% | plan? |
| Nov 1, 2017 MForm 4 → | Nov 2, 5:55 pm EDT | John TiltonChief Commercial Officer | 30,000 | $9.29 | $278,700 | 30,000 | — | plan? |
| Oct 31, 2017 SForm 4 → | Nov 2, 5:54 pm EDT | Vlad CoricChief Executive Officer, Director | 150,000 | $29.41 | $4,411,835 | 575,000 | −20.7% | plan? |
| May 9, 2017 CForm 4 → | May 11, 5:33 pm EDT | John TiltonChief Commercial Officer | 1,614 | — | — | 1,614 | — | plan? |
| May 9, 2017 PForm 4 → | May 11, 5:01 pm EDT | James EngelhartChief Financial Officer | 2,500 | $17.00 | $42,500 | 3,576 | +232% | plan? |
| May 9, 2017 PForm 4 → | May 11, 5:00 pm EDT | Charles ConwayChief Scientific Officer | 4,000 | $17.00 | $68,000 | 4,000 | — | plan? |
| May 9, 2017 PForm 4 → | May 11, 4:58 pm EDT | Robert BermanChief Medical Officer | 50 | $17.00 | $850 | 50 | — | plan? |
| May 9, 2017 CForm 4 → | May 9, 4:48 pm EDT | James EngelhartChief Financial Officer | 1,076 | — | — | 1,076 | — | plan? |
| May 9, 2017 PForm 4 → | May 9, 4:47 pm EDT | John W ChildsDirector, 10% Owner | 415,000 | $17.00 | $7,055,000 | 2,719,438 | +18.0% | plan? |
| May 9, 2017 CForm 4 → | May 9, 4:47 pm EDT | John W ChildsDirector, 10% Owner | 1,035,938 | — | — | 2,304,438 | — | plan? |
| May 9, 2017 PForm 4 → | May 9, 4:45 pm EDT | Albert ChaDirector | 470,000 | $17.00 | $7,990,000 | 1,976,818 | +31.2% | plan? |
| May 9, 2017 CForm 4 → | May 9, 4:45 pm EDT | Albert ChaDirector | 1,506,818 | — | — | 1,506,818 | — | plan? |
| May 9, 2017 PForm 4 → | May 9, 4:44 pm EDT | Gregory BaileyDirector | 175,000 | $17.00 | $2,975,000 | 1,290,299 | +15.7% | plan? |
| May 9, 2017 CForm 4 → | May 9, 4:44 pm EDT | Gregory BaileyDirector | 1,076,299 | — | — | 1,115,299 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2019 MForm 4 → | Feb 25, 4:40 pm EST | Julia P GregoryDirector | 12,000 | — | — | 24,000 | — | |
| Feb 4, 2019 MForm 4 → | Feb 6, 6:21 pm EST | Eric AguiarDirector | 17,609 | — | — | 22,827 | — | |
| Jan 10, 2019 MForm 4 → | Jan 14, 5:50 pm EST | John TiltonChief Commercial Officer | 10,500 | — | — | 10,500 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:40 pm EST | Kimberly GentileVP of Operations | 65,000 | — | — | 65,000 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:38 pm EST | Charles ConwayChief Scientific Officer | 65,000 | — | — | 65,000 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:34 pm EST | James EngelhartChief Financial Officer | 75,000 | — | — | 75,000 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:33 pm EST | John TiltonChief Commercial Officer | 30,000 | — | — | 30,000 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:32 pm EST | Vlad CoricChief Executive Officer, Director | 200,000 | — | — | 200,000 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:30 pm EST | Eric AguiarDirector | 30,000 | — | — | 30,000 | — | |
| Nov 20, 2018 AForm 5 → | Feb 14, 2019, 4:28 pm EST | Robert BermanChief Medical Officer | 20,000 | — | — | 20,000 | — | |
| Sep 7, 2018 AForm 4 → | Sep 11, 4:19 pm EDT | Robert RepellaDirector | 36,000 | — | — | 36,000 | — | |
| Jun 15, 2018 MForm 4 → | Jun 19, 4:43 pm EDT | Kimberly GentileVP of Operations | 12,500 | — | — | 25,000 | — | |
| May 30, 2018 MForm 4 → | May 30, 6:02 pm EDT | James EngelhartChief Financial Officer | 5,000 | — | — | 17,500 | — | |
| May 1, 2018 AForm 4 → | May 3, 5:25 pm EDT | Declan DooganDirector | 18,000 | — | — | 18,000 | — | |
| May 1, 2018 AForm 4 → | May 3, 5:24 pm EDT | John W ChildsDirector | 18,000 | — | — | 18,000 | — | |
| May 1, 2018 AForm 4 → | May 3, 5:23 pm EDT | Gregory BaileyDirector | 18,000 | — | — | 18,000 | — | |
| May 1, 2018 AForm 4 → | May 3, 5:22 pm EDT | Julia P GregoryDirector | 18,000 | — | — | 18,000 | — | |
| May 1, 2018 AForm 4 → | May 3, 5:21 pm EDT | Albert ChaDirector | 18,000 | — | — | 18,000 | — | |
| May 1, 2018 AForm 4 → | May 3, 5:20 pm EDT | Eric AguiarDirector | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2018 MForm 4 → | Mar 5, 4:31 pm EST | Kimberly GentileVP of Operations | 5,000 | — | — | 37,500 | — | |
| Feb 1, 2018 MForm 4 → | Feb 2, 6:18 pm EST | Kimberly GentileVP of Operations | 5,000 | — | — | 42,500 | — | |
| Jan 22, 2018 DForm 4 → | Jan 24, 7:00 pm EST | James EngelhartChief Financial Officer | 10,000 | — | — | 21,962 | — | |
| Jan 2, 2018 MForm 4 → | Jan 3, 5:28 pm EST | Kimberly GentileVP of Operations | 5,000 | — | — | 47,500 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:37 pm EST | John TiltonChief Commercial Officer | 21,740 | — | — | 21,740 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:36 pm EST | Kimberly GentileVP of Operations | 42,612 | — | — | 42,612 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:35 pm EST | James EngelhartChief Financial Officer | 78,264 | — | — | 78,264 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:34 pm EST | Charles ConwayChief Scientific Officer | 32,612 | — | — | 32,612 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:33 pm EST | Robert BermanChief Medical Officer | 20,000 | — | — | 20,000 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:32 pm EST | Vlad CoricChief Executive Officer, Director | 200,000 | — | — | 200,000 | — | |
| Dec 7, 2017 AForm 4 → | Dec 11, 5:31 pm EST | Eric AguiarDirector | 30,436 | — | — | 30,436 | — | |
| Dec 1, 2017 MForm 4 → | Dec 5, 4:02 pm EST | Kimberly GentileVP of Operations | 5,000 | — | — | 52,500 | — | |
| Nov 10, 2017 MForm 4/A → | May 11, 2018, 4:40 pm EDT | James EngelhartChief Financial Officer | 8,400 | — | — | 32,500 | — | |
| Nov 9, 2017 MForm 4 → | Nov 14, 5:52 pm EST | James EngelhartChief Financial Officer | 30,538 | — | — | 31,962 | — | late amended |
| Nov 1, 2017 MForm 4 → | Nov 2, 5:57 pm EDT | Kimberly GentileVP of Operations | 5,000 | — | — | 57,500 | — | |
| Nov 1, 2017 MForm 4 → | Nov 2, 5:55 pm EDT | John TiltonChief Commercial Officer | 30,000 | — | — | 88,792 | — | |
| Sep 5, 2017 AForm 4 → | Sep 12, 6:24 pm EDT | Eric AguiarDirector | 5,000 | — | — | 5,000 | — | late |
| Sep 5, 2017 AForm 4 → | Sep 12, 6:12 pm EDT | Kimberly GentileVP of Operations | 10,000 | — | — | 10,000 | — | late |
| Sep 5, 2017 AForm 4 → | Sep 12, 6:11 pm EDT | Charles ConwayChief Scientific Officer | 10,000 | — | — | 10,000 | — | late |
| Aug 4, 2017 AForm 4 → | Aug 8, 4:03 pm EDT | Eric AguiarDirector | 40,000 | — | — | 40,000 | — | |
| Aug 2, 2017 AForm 4 → | Aug 4, 4:12 pm EDT | Julia P GregoryDirector | 36,000 | — | — | 36,000 | — | |
| May 9, 2017 CForm 4 → | May 11, 5:33 pm EDT | John TiltonChief Commercial Officer | 1,614 | — | — | 0 | — | |
| May 9, 2017 CForm 4 → | May 9, 4:48 pm EDT | James EngelhartChief Financial Officer | 1,076 | — | — | 0 | — | |
| May 9, 2017 CForm 4 → | May 9, 4:47 pm EDT | John W ChildsDirector, 10% Owner | 1,035,938 | — | — | 0 | — | |
| May 9, 2017 CForm 4 → | May 9, 4:45 pm EDT | Albert ChaDirector | 1,506,818 | — | — | 0 | — | |
| May 9, 2017 CForm 4 → | May 9, 4:44 pm EDT | Gregory BaileyDirector | 1,076,299 | — | — | 0 | — |